PortViewPortView
Nexalin Technology logo

Nexalin Technology (NXL) Stock Analysis

NASDAQHealthcareMedical - Devices

$6.42-5.59%
1-year price historyRange $6.42 – $55.80
52-week range$6.42
$6.25$60.00

What Nexalin Technology does

Nexalin Technology, Inc. operates as a medical device firm specializing in the creation and advancement of neurostimulation therapies for mental health conditions in both the United States and China. The company commercializes its primary product, the Nexalin Device, which provides a non-invasive and drug-free treatment for anxiety and insomnia. This device functions by emitting a proprietary frequency-based waveform designed to elicit a beneficial response from mid-brain structures associated with various psychological disorders. Furthermore, Nexalin Technology is currently developing "Generation 2," a new medical device undergoing clinical trials. This future product aims to address a broader spectrum of health issues, including opiate addiction, persistent pain, Alzheimer's disease, and dementia. The company was founded in 2021 and has its headquarters in Houston, Texas.

Key metrics

Market cap
$4.71M
P/E (TTM)
-13.66
EPS (TTM)
$-0.47
Beta
4.04
Dividend yield
0.00%
Revenue / share
$0.31
50-day avg
$11.00
200-day avg
$15.52
52-week high
$60.00
52-week low
$6.25
CEO
Mark White

ETFs linked to NXL

Broad-market and Healthcare sector ETFs an investor holding Nexalin Technology is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how NXL fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze NXL in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Nexalin Technology?
Nexalin Technology trades under the ticker NXL on NASDAQ.
Which exchange is NXL listed on?
NXL is listed on NASDAQ.
What sector does Nexalin Technology operate in?
Nexalin Technology is classified in the Healthcare sector (Medical - Devices industry).
How can PortView help analyze NXL in a portfolio?
PortView shows NXL's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.